Impact of malnutrition in advanced non-small cell lung cancer

##plugins.themes.academic_pro.article.sidebar##

Published Jun 13, 2018
Download
pdf
Vol. 96 No. 1 (2018): Issue Jan 2018

##plugins.themes.academic_pro.article.main##

Saoussen Bacha
Sabrine Mejdoub El Fehri
Sonia Habibech
Sana Cheikhrouhou
Hager Racil
Naouel Chaouch
Améni sghaier
Abdellatif Chabbou

Abstract

Background: Malnutrition is so commonly associated with cancer disease. Our work aims to highlight the impact of malnutrition on the survival and toxicity of chemotherapy in patients with advanced stages of non-small cell lung cancer (NSCLC).
Methods: A retrospective study including 60 patients followed for NSCLC stage IIIB and IV, between January 2007 and December 2013. An evaluation of the impact of malnutrition was carried out according to different markers (weight loss, body mass index (BMI), albumin and NRI score). 
Results: The mean age was 59. Taking Weight loss> 10 % as a criterion of malnutrition, 22% of patients were malnourished. Based on a BMI lower than 18.5 Kg/m², 14% of patients were malnourished. Ganglionic extension, anemia and hypoalbuminaemia were associated with malnutrition (p=0.016; p=0.02 and p=0.03 respectively). The Overall survival (OS) was 2.65 months and 6.95 months (p <0.0003) in malnourished and non-malnourished groups. The definition of malnutrition can also be based on an albumin level <35 g/l. According to this criterion, 55% of the patients were undernourished. Anemia and lymphopenia were associated with malnutrition respectively (p=0.002; p=0.001). The OS was 4.45 months and 8.42 months respectively in malnourished and non-malnourished groups (p <0.0002). NRI score<100 and <97.5 (moderate to severe malnutrition) was found in respectively 100% and 74 % of patients. The OS was 4.67 months and 9.12 months respectively in moderate to severe malnutrition (NRI<97.5) and mild malnutrition groups (NRI≥97.5) (p<0.001).
Conclusion: Malnutrition was common in patients with advanced stage of NSCLC and was associated with poor prognosis.

Keywords:

malnutrition ; survival ; lung cancer ; prognosis

##plugins.themes.academic_pro.article.details##

References

  1. Dewys WD, Begg C, Lanvin PT, Band PR, Bennett JM, Bertino JR et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69(4):491-7.
  2. Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centers. Br J Cancer 2010;102(6):966-71.
  3. Xara S, Amaral TF, Parente B. Undernutrition and quality of life in non-small cell lung cancer patients. Rev Port Pneumol 2011;17(4):153-8.
  4. Barret M, Malka D, Aparicio T, Dalban C, Locher C, sabate JM et al. Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 2011;81:395-402.
  5. Pablo AM, Izaga MA, Alday LA. Assessment of nutritional status on hospital admission: nutritional scores. Eur J Clin Nutr 2003;57(7):824-31.
  6. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers ? Br J Cancer 2004;90(10):1905-11.
  7. Abeillera M. Dénutrition et toxicités des chimiothérapies dans le traitement du cancer broncho-pulmonaire [Thèse]. Médecine : Rouen ; 2015. 50p.
  8. Jeremic B, Milicic B, Dagovic A, Alexandrovic J, NiKolic N. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol. 2003;129(2):114-22.
  9. Chermiti Ben Abdellah F, Ben Said H, Chamkhi N, Ferchichi M, Chtourou A, Taktak S et al. Assessment of nutritional status in patients with primary lung cancer. Tun Med 2013;91(10):600-4.
  10. Pai C, Chuang CC, Tseng CK, Tsang NM, Chang KP, Yen TC et al. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. Int J Radiat Oncol Biol Phys 2012;83(1):93-100.
  11. Lochs H, Dervenis C. Malnutrition-the ignored risk factor. Dig Dis 2003;21:196-7.
  12. Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest 1994;105(3):760-6.
  13. Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010;10:50.
  14. Aaldriks AA, Giltay EJ, Le Cessie S, Van der Geest LG, Portielje JE, Tanis BC et al. Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy. Breast 2013;22(5):753-60.
  15. Falandry C, Weber B, Savoye AM, Tinquaut F, Tredan O, Sevin O et al. Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Ann Oncol 2013;24(11):2808-13.
  16. Paillaud E, Liuu E, Laurent M, Le Thuaut A, Vincent H, Raynaud-Simon A al. Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumour site and metastatic status. The ELCAPA-05 cohort study. Clin Nutr 2014;33(2):330-5.
  17. Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE et al. Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr 1988;47 (2 Suppl):366-81.
  18. Reinhardt GF, Myscofski JW, Wilkens DB, Dobrin PB, Mangan JE, Stannard RT. Incidence and mortality of hypoalbuminemic patients in hospitalized veterans. J Parent Enteral Nutr 1980;4(4):357-9.
  19. Martin F, Santolaria F, Batista N, Milena A, Gonzales-Reimers E, Brito MJ et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999;11(1):80-6.
  20. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991;325(8):525-32.
  21. Naber TH, Schermer T, De Bree A, Nusteling K, Eggink L, Kruimel JW et al. Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 1997;66(5):1232-9.
  22. Yim GW, Eoh KJ, Kim SW, Nam EJ, Kim YT. Malnutrition identified by the nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma. Nutr Cancer 2016;68(5):772-9.
  23. Cox S, Powell C, Carter B, Hurt C, Mukherjee S, Lewis TD. Role of nutritional status as predictor of survival in esophageal cancer treated with definitive chemoradiation (dRCT): outcome from SCOPE1, a phase II/III randomised trial of dRCT+/- cetuximab. J Clin Oncol 2016;34 (4 Suppl):103.
  24. Kaikani W, Bachmann P. Conséquences d'une comorbidité trop souvent négligée en cancérologie : la dénutrition. Bull Cancer 2009;96(6):659-64.
  25. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34(4):503-9.
  26. Alexandre J, Gross-Goupil M, Falissard B, Nguyen ML, Gornet JM, Misset JL et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe hematological toxicity following chemotherapy. Ann Oncol 2003;14(1):36-41.